CARDIOMYOPATHY ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY

被引：0
|
作者：
BECK, AC
WARD, JH
HAMMOND, EH
WRAY, RB
SAMLOWSKI, WE
机构：
[1] UNIV UTAH,VET AFFAIRS MED CTR,DEPT INTERNAL MED,CANC IMMUNOTHERAPY PROGRAM,SALT LAKE CITY,UT 84112
[2] DEPT VET AFFAIRS MED CTR,SALT LAKE CITY,UT
[3] LATTER DAY ST HOSP,DEPT PATHOL,SALT LAKE CITY,UT 84143
[4] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112
来源：
WESTERN JOURNAL OF MEDICINE | 1991年 / 155卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 296
页数：4
相关论文
共 50 条
  • [31] Resveratrol Prevents Endothelial Cells Injury in High-Dose Interleukin-2 Therapy against Melanoma
    Guan, Hongbing
    Singh, Narendra P.
    Singh, Udai P.
    Nagarkatti, Prakash S.
    Nagarkatti, Mitzi
    [J]. PLOS ONE, 2012, 7 (04):
  • [32] Nausea and vomiting during high-dose interleukin-2 (HD IL-2) therapy.
    Fesler, Mark
    Chu, Melinda Bernabe
    Armbrecht, Eric
    Fosko, Scott
    Hsueh, Eddy C.
    Richart, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] ACUTE-PANCREATITIS ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY FOR MALIGNANT-MELANOMA
    BIRCHFIELD, GR
    WARD, JH
    REDMAN, BG
    FLAHERTY, L
    SAMLOWSKI, WE
    [J]. WESTERN JOURNAL OF MEDICINE, 1990, 152 (06): : 714 - 716
  • [34] SEVERE REVERSIBLE GLOBAL AND REGIONAL VENTRICULAR DYSFUNCTION ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY
    DUBOIS, JS
    UDELSON, JE
    ATKINS, MB
    [J]. JOURNAL OF IMMUNOTHERAPY, 1995, 18 (02): : 119 - 123
  • [35] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [36] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [37] HIGH-DOSE INTERLEUKIN-2 PROMOTES BACTERIAL TRANSLOCATION FROM THE GUT
    REYNOLDS, JV
    MURCHAN, P
    LEONARD, N
    GOUGH, DB
    CLARKE, P
    KEANE, FBV
    TANNER, WA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (03) : 634 - 636
  • [38] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 AND ACUTE MYELOID LEUKEMIAS IN RELAPSE
    MARANINCHI, D
    BLAISE, D
    VIENS, P
    BRANDELY, M
    OLIVE, D
    LOPEZ, M
    SAINTY, D
    MARIT, G
    STOPPA, AM
    REIFFERS, J
    GRATECOS, N
    BERTAUPEREZ, P
    MANNONI, P
    MAWAS, C
    HERCEND, T
    SEBAHOUN, G
    CARCASSONNE, Y
    [J]. BLOOD, 1991, 78 (09) : 2182 - 2187
  • [39] High-dose recombinant interleukin-2/verapamil combination in advanced cancer
    Tagliaferri, P
    Correale, P
    Mottola, M
    deSimone, G
    Montesarchio, V
    Matano, E
    Rea, A
    Morabito, A
    Famiani, M
    Ciardiello, F
    Tortora, G
    Caraglia, M
    Barile, C
    Palmieri, G
    Bianco, AR
    [J]. EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1436 - 1437
  • [40] High-dose interleukin-2 is an intensive treatment regardless of the venue of administration
    Schwartzentruber, DJ
    [J]. CANCER JOURNAL, 2001, 7 (02): : 103 - 104
12345